Nisa Investment Advisors, LLC Royalty Pharma PLC Transaction History

Nisa Investment Advisors, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 25, 2024	BUY	$26.21 - $29.22 $1.81 Million - $2.01 Million	68,900 Added 1129.51%	75,000 $2.11 Million
Q3 2023 Nov 02, 2023	SELL	$26.26 - $31.38 $128,674 - $153,762	-4,900 Reduced 44.55%	6,100 $165,000
Q2 2023 Aug 11, 2023	BUY	$29.6 - $36.56 $198,320 - $244,952	6,700 Added 155.81%	11,000 $338,000
Q1 2023 May 02, 2023	SELL	$32.77 - $39.4 $4.9 Million - $5.89 Million	-149,519 Reduced 97.2%	4,300 $155,000
Q4 2022 Feb 02, 2023	BUY	$39.17 - $44.04 $5.63 Million - $6.33 Million	143,660 Added 1414.12%	153,819 $6.08 Million
Q3 2022 Nov 07, 2022	BUY	$39.88 - $44.65 $405,140 - $453,599	10,159 New	10,159 $415,000
Q1 2022 Apr 29, 2022	SELL	$37.46 - $42.44 $346,280 - $392,315	-9,244 Closed	0 $0
Q4 2021 Feb 03, 2022	SELL	$35.17 - $42.48 $62,708 - $75,741	-1,783 Reduced 16.17%	9,244 $370,000
Q3 2021 Oct 18, 2021	BUY	$36.14 - $42.24 $398,515 - $465,780	11,027 New	11,027 $399,000

412

283M

578K

47.5K

Ticker RPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 437,139,008
Market Cap $11.2B
Description
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...

Get notified when there are updates to the investment portfolio of Nisa Investment Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Nisa Investment Advisors, LLC with notifications on news.